Literature DB >> 29081504

Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents.

G Twig1,2,3,4, N Geva2, H Levine5, E Derazne2,4, N Goldberger6, Z Haklai6, A Leiba2,4,7, J D Kark5.   

Abstract

BACKGROUND: Obesity was linked to altered immunity, but also to favorable outcomes among patients with infectious disease (ID) in some settings. We assessed the association between adolescent body mass index (BMI) and ID mortality.
METHODS: BMI of 2 294 139 Israeli adolescents (60% men; age 17.4±0.3 years) was measured between 1967 and 2010. The outcome, obtained by linkage with official national records, was death due to ID as the underlying cause. Multivariable Cox proportional hazards models were applied.
RESULTS: During 42 297 007 person-years of follow-up (median 18.4 years), there were 689 deaths from ID (mean age 44.1±10.5 years). Adjusted hazard ratios (HR) were 1.039 (1.011-1.068) and 1.146 (1.099-1.194) among men and women, respectively, per unit increment in BMI (P for sex interaction=4.4 × 10-5). Adjusted hazard ratios among men were 1.2 (1.0-1.5), 1.9 (1.4-2.5) and 2.5 (1.5-4.2) for those with high-normal BMI (22.0-24.9 kg m-2), overweight and obese, respectively, compared with the 18.5⩽BMI<22 kg m-2 reference group, and 1.7 (1.1-2.6), 2.6 (1.6-4.3) and 6.6 (3.3-13.1) among women, respectively. The increased risk among underweight (<18.5 kg m-2) boys was attenuated when the study sample was restricted to those with unimpaired health at baseline. A multivariable spline model indicated a minimum risk for total ID mortality at 20.7 and 18.0 kg m-2 for men and women, respectively, with significantly increased risk seen above adolescent BMI values of 23.6 and 24.0 kg m-2, respectively. The association with BMI was particularly evident for bacterial infections (predominantly sepsis), airways and central nervous system infections (63% of the ID deaths).
CONCLUSIONS: Adolescent overweight and obesity were strongly associated with ID mortality, especially of bacterial origin and among women.

Entities:  

Mesh:

Year:  2017        PMID: 29081504     DOI: 10.1038/ijo.2017.263

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  47 in total

Review 1.  Obesity and infection.

Authors:  Matthew E Falagas; Maria Kompoti
Journal:  Lancet Infect Dis       Date:  2006-07       Impact factor: 25.071

2.  Impact of gender on sepsis mortality and severity of illness for prepubertal and postpubertal children.

Authors:  Anoopindar K Ghuman; Christopher J L Newth; Robinder G Khemani
Journal:  J Pediatr       Date:  2013-05-21       Impact factor: 4.406

3.  Trends in 393 necrotizing acute soft tissue infection patients 2000-2008.

Authors:  Nicole P Bernal; Barbara A Latenser; Janelle M Born; Junlin Liao
Journal:  Burns       Date:  2011-10-24       Impact factor: 2.744

4.  Childhood obesity, other cardiovascular risk factors, and premature death.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

Review 5.  The weight of obesity on the human immune response to vaccination.

Authors:  Scott D Painter; Inna G Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2015-07-08       Impact factor: 3.641

Review 6.  Potential therapeutic targets for sepsis in women.

Authors:  Maximilian Weniger; Jan G D'Haese; Martin K Angele; Irshad H Chaudry
Journal:  Expert Opin Ther Targets       Date:  2015-06-17       Impact factor: 6.902

7.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

8.  Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study.

Authors:  Vasilis Kontis; Colin D Mathers; Jürgen Rehm; Gretchen A Stevens; Kevin D Shield; Ruth Bonita; Leanne M Riley; Vladimir Poznyak; Robert Beaglehole; Majid Ezzati
Journal:  Lancet       Date:  2014-05-02       Impact factor: 79.321

9.  Use of self-reported height and weight biases the body mass index-mortality association.

Authors:  S W Keith; K R Fontaine; N M Pajewski; T Mehta; D B Allison
Journal:  Int J Obes (Lond)       Date:  2010-08-03       Impact factor: 5.095

10.  Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia.

Authors:  Reetta Huttunen; Janne Laine; Jukka Lumio; Risto Vuento; Jaana Syrjänen
Journal:  BMC Infect Dis       Date:  2007-03-09       Impact factor: 3.090

View more
  11 in total

1.  The Association between Increased Body Mass Index and Overuse Injuries in Israel Defense Forces Conscripts.

Authors:  Netanel A Hollander; Aharon S Finestone; Victoria Yofe; Tarif Bader; Racheli Magnezi
Journal:  Obes Facts       Date:  2020-02-13       Impact factor: 3.942

2.  Diet-induced obesity in mice impairs host defense against Klebsiella pneumonia in vivo and glucose transport and bactericidal functions in neutrophils in vitro.

Authors:  Peter Mancuso; Jeffrey L Curtis; Anne M Weitzel; Cameron A Griffin; Benjamin Bouchard; Christine M Freeman; Dave Bridges; Kanakadurga Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-01       Impact factor: 6.011

3.  Cognitive function in adolescence and the risk for premature diabetes and cardiovascular mortality in adulthood.

Authors:  Gilad Twig; Amir Tirosh; Estela Derazne; Ziona Haklai; Nehama Goldberger; Arnon Afek; Hertzel C Gerstein; Jeremy D Kark; Tali Cukierman-Yaffe
Journal:  Cardiovasc Diabetol       Date:  2018-12-05       Impact factor: 9.951

4.  Obesity and Type 2 Diabetes mellitus induce lipopolysaccharide tolerance in rat neutrophils.

Authors:  Wilson Mitsuo Tatagiba Kuwabara; Caroline Naomi Fukusawa Yokota; Rui Curi; Tatiana Carolina Alba-Loureiro
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

5.  Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection.

Authors:  Ichiro Misumi; Joshua Starmer; Toru Uchimura; Melinda A Beck; Terry Magnuson; Jason K Whitmire
Journal:  Cell Rep       Date:  2019-04-09       Impact factor: 9.423

6.  The Association Between Body Mass Index and the Risk of Hospitalization and Mortality due to Infection: A Prospective Cohort Study.

Authors:  Wei-Shun Yang; Yi-Cheng Chang; Chia-Hsuin Chang; Li-Chiu Wu; Jiun-Ling Wang; Hsien-Ho Lin
Journal:  Open Forum Infect Dis       Date:  2020-10-11       Impact factor: 3.835

7.  BMI in early adulthood is associated with severe COVID-19 later in life: A prospective cohort study of 1.5 million Swedish men.

Authors:  Josefina Robertson; Martin Adiels; Lauren Lissner; Kirsten Mehlig; Agnes Af Geijerstam; Martin Lindgren; Magnus Gisslén; Elin Ekblom Bak; Annika Rosengren; Maria Åberg
Journal:  Obesity (Silver Spring)       Date:  2022-02-15       Impact factor: 9.298

Review 8.  Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).

Authors:  Yue Zhou; Jingwei Chi; Wenshan Lv; Yangang Wang
Journal:  Diabetes Metab Res Rev       Date:  2020-07-20       Impact factor: 8.128

9.  Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity.

Authors:  Cole D Bendor; Aya Bardugo; Orit Pinhas-Hamiel; Arnon Afek; Gilad Twig
Journal:  Cardiovasc Diabetol       Date:  2020-06-13       Impact factor: 9.951

10.  Body mass index and risk of dying from a bloodstream infection: A Mendelian randomization study.

Authors:  Tormod Rogne; Erik Solligård; Stephen Burgess; Ben M Brumpton; Julie Paulsen; Hallie C Prescott; Randi M Mohus; Lise T Gustad; Arne Mehl; Bjørn O Åsvold; Andrew T DeWan; Jan K Damås
Journal:  PLoS Med       Date:  2020-11-16       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.